Zum Hauptinhalt springen


May: Skin Cancer Treatment Awareness Month.

Focusing on Treatment Education this May for Skin Cancer Awareness Month

OncoBeta® GmbH, a global medical device company specialising in innovative therapies for non-melanoma skin cancers (NMSCs), is supporting World Skin…

Read more

Fully recruited EPIC-Skin international study for the treatment of Non-Melanoma Skin Cancer

Garching n. Munich, Germany – OncoBeta® GmbH, a medical device company specialised in innovative epidermal radioisotope therapies, has confirmed the…

Read more

Skin: Below the Surface

We are thrilled to announce our participation in the programme ‘Skin: Below the Surface’ by the British Skin Foundation in cooperation with ITN…

Read more

GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer

OncoBeta® GmbH and GenesisCare have partnered to offer a breakthrough treatment for non-melanoma skin cancer. This partnership addresses Australia's…

Read more

Patient Frank Pattison talks about his experience - Channel 9 News

Listen to what Frank and his daughter have to say about the wonderful results achieved with the Rhenium-SCT on a Basel-Cell-Carcinoma on his ear.

Read more

Rhenium-SCT Rostock Trial results to be presented at EANM

This year the last patient in the Rhenium-SCT Rostock Trial had his final, 12 month follow up visit at the University Clinic in Rostock

The team from…

Read more

German skin cancer patients join the EPIC-Skin study


Garching, Munich. Germany – OncoBeta® GmbH has announced University Clinic of Rostock (is particpating in the global phase IV EPIC-Skin Study (Effic…

Read more

Interview with Dr. Joe Cardaci: committee member of the international Registry


Dr. Joe Cardaci, committee member of the international Registry, tells us a bit about his experience with the Rhenium-SCT and this world-first…

Read more

Rhenium-SCT reached Canadian medical news in LePatient

The non-invasive, single-session treatment for non-melanoma skin cancer, Rhenium-SCT, reached Canadian medical news. Le Patient, distributed by the…

Read more

Perth skin cancer patients undergo first treatments with OncoBeta’s Rhenium-SCT as part of the EPIC-Skin study

Perth, Australia– OncoBeta® GmbH today announced Perth’s Hollywood Private Hospital in Australia is the latest medical facility to participate in the…

Read more